BioHarvest Sciences Inc. Common Stock (BHST NASDAQ) stock market data APIs
$1.5283
0.07(4.6%)
as of November 3, 2026
Try our APIs with
free plan!
BioHarvest Sciences Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
Prev. Close
1.5283
Open
1.5939
High
1.6036
Low
1.5155
52 wk Range
1.371-9.25
Market Cap
34 908 K
Shares Outstanding
22 668 K
Revenue
35 477 K
EPS
-0.17
Beta
1.293
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BioHarvest Sciences Inc. Common Stock data using free add-ons & libraries
Get BioHarvest Sciences Inc. Common Stock Fundamental Data
BioHarvest Sciences Inc. Common Stock Fundamental data includes:
- Net Revenue: 35 477 K
- EBITDA: -5 804 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get BioHarvest Sciences Inc. Common Stock Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-08-11
- EPS/Forecast: -0.13
Get BioHarvest Sciences Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BioHarvest Sciences Inc. Common Stock News
New
What Does Tate & Lyle (LSE:TATE) Sweetener Milestone Mean For Its Growth Story?
Tate & Lyle (LSE:TATE) and BioHarvest Sciences reported a key milestone in next generation sweetener development on 22 October 2026. The partners confirmed BioHarvest's Botanical Synthesis platform ca...
Tate & Lyle (LSE:TATE) Hits Sweetener Milestone, Is The Stock Already Above Fair Value?
Tate & Lyle (LSE:TATE) stock is in focus after the group and BioHarvest Sciences reported a key milestone in their next generation sweetener programme using the Botanical Synthesis platform. The next...
Tate & Lyle (LSE:TATE) Reaches Next Generation Sweetener Milestone
Tate & Lyle (LSE:TATE) and BioHarvest Sciences reported a key milestone in developing a next generation sweetener using the Botanical Synthesis™ platform. The partners confirmed successful productio...
Tate & Lyle and Bioharvest Reach Key Milestone in Next-Generation Sweetener Development Programme
Progress demonstrates that BioHarvest's Botanical Synthesis(TM) platform is capable of producing the targeted next-generation sweetening solution Vancouver, British Columbia and Rehovot, Israel--(New...
Get BioHarvest Sciences Inc. Common Stock fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.